Logo image of CMBT.BR

CMB TECH NV (CMBT.BR) Stock Fundamental Analysis

Europe - EBR:CMBT - BE0003816338 - Common Stock

7.965 EUR
-0.17 (-2.03%)
Last: 9/19/2025, 3:11:07 PM
Fundamental Rating

4

Taking everything into account, CMBT scores 4 out of 10 in our fundamental rating. CMBT was compared to 65 industry peers in the Oil, Gas & Consumable Fuels industry. While CMBT has a great profitability rating, there are quite some concerns on its financial health. CMBT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
CMBT had a positive operating cash flow in the past year.
Of the past 5 years CMBT 4 years were profitable.
CMBT had a positive operating cash flow in 4 of the past 5 years.
CMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFCMBT.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

With an excellent Return On Assets value of 12.31%, CMBT belongs to the best of the industry, outperforming 93.85% of the companies in the same industry.
With an excellent Return On Equity value of 79.11%, CMBT belongs to the best of the industry, outperforming 98.46% of the companies in the same industry.
CMBT has a worse Return On Invested Capital (5.06%) than 61.54% of its industry peers.
CMBT had an Average Return On Invested Capital over the past 3 years of 8.95%. This is in line with the industry average of 9.96%.
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROIC 5.06%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
CMBT.BR Yearly ROA, ROE, ROICCMBT.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBT's Profit Margin of 72.50% is amongst the best of the industry. CMBT outperforms 98.46% of its industry peers.
CMBT's Profit Margin has improved in the last couple of years.
CMBT's Operating Margin of 35.88% is fine compared to the rest of the industry. CMBT outperforms 80.00% of its industry peers.
CMBT's Operating Margin has improved in the last couple of years.
CMBT's Gross Margin of 58.65% is fine compared to the rest of the industry. CMBT outperforms 70.77% of its industry peers.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT.BR Yearly Profit, Operating, Gross MarginsCMBT.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

CMBT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CMBT has less shares outstanding
CMBT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CMBT is higher compared to a year ago.
CMBT.BR Yearly Shares OutstandingCMBT.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT.BR Yearly Total Debt VS Total AssetsCMBT.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.75, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
CMBT has a Altman-Z score of 0.75. This is in the lower half of the industry: CMBT underperforms 75.38% of its industry peers.
A Debt/Equity ratio of 3.75 is on the high side and indicates that CMBT has dependencies on debt financing.
CMBT has a Debt to Equity ratio of 3.75. This is amonst the worse of the industry: CMBT underperforms 90.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Altman-Z 0.75
ROIC/WACC0.7
WACC7.26%
CMBT.BR Yearly LT Debt VS Equity VS FCFCMBT.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

A Current Ratio of 0.77 indicates that CMBT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.77, CMBT is doing worse than 87.69% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that CMBT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.70, CMBT is doing worse than 87.69% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.7
CMBT.BR Yearly Current Assets VS Current LiabilitesCMBT.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

CMBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -99.67%.
Measured over the past years, CMBT shows a very strong growth in Earnings Per Share. The EPS has been growing by 43.41% on average per year.
Looking at the last year, CMBT shows a very negative growth in Revenue. The Revenue has decreased by -23.87% in the last year.
Measured over the past years, CMBT shows a small growth in Revenue. The Revenue has been growing by 0.55% on average per year.
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
Revenue 1Y (TTM)-23.87%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%

3.2 Future

The Earnings Per Share is expected to decrease by -39.46% on average over the next years. This is quite bad
CMBT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.58% yearly.
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue Next Year45.47%
Revenue Next 2Y36.6%
Revenue Next 3Y31.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT.BR Yearly Revenue VS EstimatesCMBT.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CMBT.BR Yearly EPS VS EstimatesCMBT.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 398.25, the valuation of CMBT can be described as expensive.
CMBT's Price/Earnings ratio is a bit more expensive when compared to the industry. CMBT is more expensive than 70.77% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.41. CMBT is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 4.95 indicates a rather cheap valuation of CMBT.
Based on the Price/Forward Earnings ratio, CMBT is valued cheaper than 93.85% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.88. CMBT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 398.25
Fwd PE 4.95
CMBT.BR Price Earnings VS Forward Price EarningsCMBT.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CMBT is valued a bit more expensive than 72.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.11
CMBT.BR Per share dataCMBT.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

CMBT has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CMBT's earnings are expected to decrease with -39.46% in the coming years.
PEG (NY)N/A
PEG (5Y)9.17
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%

0

5. Dividend

5.1 Amount

No dividends for CMBT!.
Industry RankSector Rank
Dividend Yield N/A

CMB TECH NV

EBR:CMBT (9/19/2025, 3:11:07 PM)

7.965

-0.17 (-2.03%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-13 2025-11-13/bmo
Inst Owners1.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.52B
Analysts82
Price Target9.9 (24.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.85
Dividend Growth(5Y)116.35%
DP109.72%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-99.31%
Min EPS beat(2)-149.02%
Max EPS beat(2)-49.61%
EPS beat(4)1
Avg EPS beat(4)9.95%
Min EPS beat(4)-149.02%
Max EPS beat(4)242.1%
EPS beat(8)5
Avg EPS beat(8)86.48%
EPS beat(12)8
Avg EPS beat(12)69.92%
EPS beat(16)10
Avg EPS beat(16)53.9%
Revenue beat(2)1
Avg Revenue beat(2)0.7%
Min Revenue beat(2)-9.81%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)5.75%
Min Revenue beat(4)-9.81%
Max Revenue beat(4)15.33%
Revenue beat(8)6
Avg Revenue beat(8)28.28%
Revenue beat(12)10
Avg Revenue beat(12)38.19%
Revenue beat(16)14
Avg Revenue beat(16)43.66%
PT rev (1m)-7.62%
PT rev (3m)-12.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.05%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)10.92%
Revenue NY rev (3m)35.76%
Valuation
Industry RankSector Rank
PE 398.25
Fwd PE 4.95
P/S 2.13
P/FCF N/A
P/OCF 11.08
P/B 2.32
P/tB 2.72
EV/EBITDA 12.11
EPS(TTM)0.02
EY0.25%
EPS(NY)1.61
Fwd EY20.18%
FCF(TTM)-2.52
FCFYN/A
OCF(TTM)0.72
OCFY9.03%
SpS3.74
BVpS3.43
TBVpS2.92
PEG (NY)N/A
PEG (5Y)9.17
Profitability
Industry RankSector Rank
ROA 12.31%
ROE 79.11%
ROCE 6.75%
ROIC 5.06%
ROICexc 5.18%
ROICexgc 5.31%
OM 35.88%
PM (TTM) 72.5%
GM 58.65%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)8.95%
ROIC(5y)N/A
ROICexc(3y)9.88%
ROICexc(5y)N/A
ROICexgc(3y)9.93%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 3.75
Debt/FCF N/A
Debt/EBITDA 7.03
Cap/Depr 666.34%
Cap/Sales 86.55%
Interest Coverage 3.85
Cash Conversion 39.32%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.7
Altman-Z 0.75
F-Score2
WACC7.26%
ROIC/WACC0.7
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-99.67%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-127.37%
EPS Next Y-68.44%
EPS Next 2Y-28.34%
EPS Next 3Y-39.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.87%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%53.89%
Revenue Next Year45.47%
Revenue Next 2Y36.6%
Revenue Next 3Y31.58%
Revenue Next 5YN/A
EBIT growth 1Y-38.91%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year67.95%
EBIT Next 3Y22.95%
EBIT Next 5YN/A
FCF growth 1Y-783.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.61%
OCF growth 3YN/A
OCF growth 5Y11.04%